Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
RLFTY
)
2.440
UNCHANGED
Streaming Delayed Price
Updated: 12:18 PM EST, Jan 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about RLFTY
< Previous
1
2
3
4
5
Next >
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
December 23, 2025
Via
ACCESS Newswire
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
December 15, 2025
Via
ACCESS Newswire
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
November 14, 2025
Via
ACCESS Newswire
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
October 29, 2025
Via
ACCESS Newswire
Relief Therapeutics Publishes 2025 Half-Year Report
August 14, 2025
Via
ACCESS Newswire
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
December 16, 2024
Via
ACCESSWIRE
Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations
December 13, 2024
Via
ACCESSWIRE
Relief Therapeutics Advances Publication of 2025 Half-Year Report
August 11, 2025
Via
ACCESS Newswire
Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze
July 29, 2025
Via
ACCESS Newswire
Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011
June 20, 2025
Via
ACCESS Newswire
Relief Therapeutics Announces Results of Annual General Meeting
June 12, 2025
Via
ACCESS Newswire
Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011
May 22, 2025
Via
ACCESS Newswire
Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update
August 29, 2024
Via
ACCESSWIRE
Relief Therapeutics Secures up to $11 Million from Royalty Sales
August 04, 2024
Via
ACCESSWIRE
Relief Therapeutics Publishes 2025 Annual General Meeting Agenda
May 15, 2025
Via
ACCESS Newswire
Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update
April 10, 2025
Via
ACCESS Newswire
Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion
March 06, 2025
Via
ACCESS Newswire
Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011
February 11, 2025
Via
ACCESS Newswire
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US
January 22, 2025
Via
ACCESS Newswire
Relief Therapeutics Provides Update on Potential Transaction with Renexxion
December 27, 2024
Via
ACCESSWIRE
Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
November 10, 2024
Via
ACCESSWIRE
Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger
November 03, 2024
Via
ACCESSWIRE
Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE
October 28, 2024
Via
ACCESSWIRE
Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents
October 24, 2024
Via
ACCESSWIRE
Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment
October 20, 2024
Via
ACCESSWIRE
Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
October 07, 2024
Via
ACCESSWIRE
Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria
October 03, 2024
Via
ACCESSWIRE
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024
September 17, 2024
Via
ACCESSWIRE
Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024
September 01, 2024
Via
ACCESSWIRE
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
June 27, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
